Science needs to run fast, so do we!
As our CEO said: “Science needs to run fast, so do we!” On the occasion of the hashtag#WC2024, Takis organized the “Takis Race” on September 19th, the final day of the conference, under the motto “Run like a scientist.” It was an initiative to support the scientific hashtag#research and bring together experts of the field, […]
What’s better than an “aperitivo” on the beach to celebrate the start of the summer holidays?
At Takis, we will continue to be open during August, delivering our services without interruption. However, we know that in Italy many take their holidays during August, including members of our staff of course, so we wanted to spend a moment together to wish everyone good holidays. It was a great opportunity to thank our […]
Takis at the RomeTechnopole Spoke 6 – International Young Researcher Workshop!
This workshop was held last week at Sapienza Università di Roma and our team, led by our CTO Giuseppe Roscilli, was there to share some of our cutting-edge hashtag#research projects. Valerio Chiarini, Ph.D. presented on “MATCH: An in-silico drive-through for mAbs discovery”. This innovative project utilizes ENEA’s High Performance Computing (HPC) resources to integrate in […]
On July 8th, Federica Signoretti and Matthew Golden from the U.S. Embassy came to Takis to learn about our company, our history, and the programs we are developing.
It was a pleasure to welcome the #embassy representatives and share with them our progress and #innovations in #research and #biotechnology. We had the opportunity to discuss our current initiatives and future projects including #cancer therapies and #immunization technologies. We thank the U.S. Embassy for their pleasant visit and interest in our company. Their presence […]
Takis at EACR2024: Innovation in Cancer Therapy
We are excited to share our recent participation in the EACR2024 #event in Rotterdam, where laura luberto and Alessia Muzi presented the results of one of our latest #research projects in cancer therapy. Our research focuses on the HER3 receptor, a crucial member of the ErbB receptor family, known for its role in cellular regulation […]
Takis participated at the Flagship Project 7 Mid-term plenary workshop!
Takis participated at the Flagship Project 7 Mid-term plenary #workshop! But first… what’s Flagship Project 7? Flagship Project 7 (FP7) is one of eight projects under the #RomeTechnopole initiative: a set of initiatives that bring vertical innovation within strategic specialization areas such as Energy Transition, Digital Transition, and #Health & #BioPharma. FP7 is led by […]
We are thrilled to announce that Takis has been selected among 13 European companies for the IPCEI “Med4Cure” project, the first Important Project of Common European Interest in the Health value chain.
The Med4Cure project supports #research, innovation and the industrial deployment of pioneering #healthcare products and processes. Our project, Zetesis X-eVax, aims to create an Italian center of excellence for research and development, focusing on innovative #vaccines and hashtag#gene therapies. This includes developing new generation vaccines for COVID-19 and Malaria, as well as #cancer treatments. Being […]
Biotechnologies are emerging as key strategies for citizens’ health and for countries economy
A highly productive meeting about this and other relevant topics took place between our CEO, Luigi Aurisicchio, and the United States Ambassador, Jack Markell, and his team at Villa Taverna in Rome. Investing in R&D along with sharing the US and Italy strengths, business models and expertise will definitely lead to new important opportunities. We […]
CEO, Luigi Aurisicchio, recently joined the event Italy and Latin America
Our CEO, Luigi Aurisicchio, recently joined the event “Italy and Latin America: Exploring New Frontiers in Biotechnology and Life Sciences,” organized by IILA, the Embassy of Chile in Italy, and the Biotech Academy of Rome. This important gathering highlighted prospects, opportunities, and challenges for biotechnological development and training. Luigi showcased Takis’s innovative services and the […]
authorization as a facility user for animal experimentation for our recently acquired BSL-3 facility
We are proud to announce that we have received authorization as a facility user for animal experimentation for our recently acquired BSL-3 facility! We are now one step closer to making our BSL-3 operational, paving the way for new interesting perspectives in our research. This facility aims to become one of the points of reference […]